Summary The expression of HLA class I antigens was studied in 99 primary tumours (colorectal, gastric and laryngeal carcinomas) and 57 autologous metastases using immunohistological techniques and monoclonal antibodies against class I monomorphic determinants, HLA-B isotypic determinants and HLA polymorphic determinants. Fourteen per cent of colorectal, 9.6% of gastric and 20% of laryngeal carcinomas completely lacked class I molecules. Selective losses of HLA-B antigens were also detected in 8.8, 3.4 and 5.8% of these tumours respectively. Taking into account complete and selective loss of HLA-B the average alteration in the class I molecules expression totalled 21%. The comparison of class I expression between primary tumours and autologous metastases showed differences in 24% of the patients. These differences consisted mainly in a decrease of class I expression by metastases. Nevertheless, four types of divergence were detected in laryngeal carcinomas, namely: + / -, + / +, -/ +, -/-. In addition, a clear correlation between degree of differentiation and class I expression was observed in laryngeal tumours. Finally, when class I gene RFLPs were compared with DNA from 15 tumours and autologous normal mucosa or peripheral lymphocytes, no differences were detected between these samples.
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Major histocompatibility antigens (H-2 in mice and HLA in man) were discovered thanks to their role in alloimmune interactions, generating alloantibodies and alloreactive CTLs when transplants were performed between genetically different individuals (Gorer et al., 1948) . However, their physiological function remains obscure. These antigens are controlled by a cluster of genes located in chromosome 17 in mice and chromosome 6 in humans. These genes code for the classical transplantation antigens (class I), the immune response associated antigens (class II) and complement genes (class III) (Dausset, 1981) . Class I antigens are cell surface glycoproteins composed of a highly polymorphic heavy chain (Mr 45,000) associated in a non-covalent way to fl2-microglobulin (Ploegh et al., 1981) . Class I molecules are widely distributed and expressed in most, but not all, nucleated cells (Daar et al., 1984) . Class II antigens are composed of two glycosylated chains (Mr 32,000 and 29,000 respectively) (Cullen et al., 1974) , and are predominantly expressed by cells involved in immunological phenomena (B cells, antigen presenting cells and activated T lymphocytes) (Engleman et al., 1980) . Histocompatibility class I and II antigens are involved in different immunological and probably non-immunological phenomena (Klein, 1986) . Cytotoxic T-lymphocytes recognise antigens in association with class I molecules (Zinkernagel & Docherty, 1974) , and natural killer cell cytotoxicity has been shown to be inversely correlated with the degree of class I expression (Kiirre, 1986) . It is therefore becoming evident that the immune response against modified cells, virus infected cells or tumour cells is not only influenced by the nature of the specific antigens but also by the quantity and quality of class I molecules present at the tumour cell surface (Fentestein & Schmidt, 1981 , Garrido, 1988 .
There is an increasing body of evidence which suggests that MHC class I antigen expression is altered on mouse as well as on human tumours (Fentestein & Garrido, 1986 class I antigens (Garrido et al., 1979; Schirrmacher et al., 1981) ; and (b) expression of aberrant class I-like molecules (Orgad et al., 1985; Garrido et al., 1976b; Phillips et al., 1986) . Furthermore, some reports indicate that these alterations may play a crucial role in tumour dissemination and metastasis (Eisenbach et al., 1985) .
We (Boyum, 1968) and HLA typed by standard method microcytotoxicity (Terasaki & McClelland, 1964) . Tumour HLA typing was performed by immunohistochemical techniques on cryostatic sections (Cordell et al., 1984 (Cordell et al., 1984) .
DNA isolation and Southern blot analysis High molecular weight DNA was isolated from the tumours, normal autologous mucosa and autologous peripheral blood lymphocytes (Blin & Stafford, 1976 (Southern, 1975) . A 1.4 Kbp cDNA coding for HLA-B7 (pDP-001) was used as a probe (Sood et al., 1981 (Table I) . MoAbs were used against monomorphic determinants of HLA-A, B and C and fl2-microglobulin. There was no discrepancy among the reaction patterns obtained with these MoAbs. However, differences were observed in three patients (8.8%) when two HLA-B locus specific MoAbs were used. These three patients showed selective losses of HLA-B products. Samples of normal mucosa from the same patients distal or closer to the tumour were also studied. Benign lesions (adenomas) were also included in the protocol. No alteration in class I expression was observed in these samples. Nor was any correlation found between the partial or complete loss of class I antigen expression and the degree of differentiation of the primary colorectal tumours studied (Table II) .
The 13 colorectal metastases studied were class I positive. Nevertheless, eight metastases presented a lower percentage of positive cells than the autologous primary tumours (Table   III) .
Gastric carcinomas Thirty-one primary gastric carcinomas were studied. Class I antigens were completely absent in three patients (9.6%) ( Table I) . Heterogeneous expression was observed in five patients (16.1%) (between 25 and 75% positive cells). Twenty-two patients (71.1%) showed positive and heterogeneous class I expression. Selective loss of HLA-B locus antigen was found in only one tumour.
HLA class I expression was considerable in 16/19 poorly differentiated gastric carcinomas, whereas only 6/12 well differentiated carcinomas were positive (Table II) . Interestingly, normal gastric mucosa showed weak, heterogeneous HLA-A, B and C antigen expression. Thirty lymph node metastases were studied, of which 27 were found to be class I positive and three class I negative (Table III) . Hence the vast majority of lymph node metastases derived from gastric tumours were class I positive.
Laryngeal carcinomas Thirty-four primary laryngeal carcinomas were studied, seven of which (20.5%) were class I negative. In addition, B-locus losses were observed in two tumours (5.8%) ( Table I ). The degree of differentiation was II  III  I  II  III  I  II  III  100  8  10  3  1  5  16  8  16  -75-25  1  2  2   -3  2  --1  <25  1  3  1  1  1  1 (Table II) . It was observed that normal laryngeal mucosa was always class I positive, presenting a homogeneous staining pattern. Fourteen autologous metastases were studied, of which nine were found to be class I positive and five class I negative (Table  III) .
Differences in HLA class I expression between primary tumours and autologous metastases The class I expression of 57 metastases was compared with that of their autologous primary tumours. In most of the patients there was no detectable difference. In eight patients with colonic carcinoma and two with gastric carcinoma a decrease in the number of HLA class I positive cells was observed on the metastases (Table IV) . In six laryngeal carcinomas, four possible combinations of expression between the primary tumour and its autologous metastases ( + / +, + /-, -/+, -I-) were found (Table IV) .
Selective loss of HLA-B locus products Six of 99 primary tumours (6%) were found to be selective for HLA-B antigen losses ( Table I ). Considering that the amount of HLA class I losses reached 15% (15/99) we believe that the 6% of B-locus losses should be added to this figure, resulting in a total of 21%.
One case was selected from each tumour group to confirm the HLA-B antigen loss. These three patients were HLA typed using the standard Terasaki microcytotoxicity test on PBLs. Tumour tissue was typed on frozen sections with polymorphic HLA reagents using the immune alkaline phosphatase technique, in conjunction with MoAbs defining polymorphic HLA determinants. These MoAbs were developed at the Xth International HLA workshop and define the following specificities: A2, Al1, B5, B14, B21, B44 and Bw4 (Table V) .
The loss of B locus products in these tumours was confirmed with polymorphic MoAbs. In all cases positive reaction with the infiltrating lymphocytes was used as the internal control. In one gastric tumour, HLA-A locus antigens were also undetectable despite a positive reaction with W6/32 and f2-microglobulin. moderately differentiated; III, poorly differentiated. (Figure 2) . We also included methylation sensitive enzymes, which failed to detect differences between tumour and normal mucosa DNA. 
Discussion
The phenotypic analysis of HLA class I molecules on colorectal, gastric and laryngeal carcinomas with MoAbs directed against monomorphic determinants reveals three different reaction patterns: positive, heterogeneous and negative.
Heterogeneity of class I expression has previously been detected in breast carcinoma (Natali et al., 1983; Perez et al., 1986) and in melanoma (Albino et al., 1981) . The most widely accepted explanation to date is based on the appearance of clones with differential HLA class I expression in the course of tumour progression (Ruiz-Cabello et al., 1987) .
The loss of HLA class I expression is a relatively frequent event in human neoplasias, and has been correlated with the degree of differentiation in embryonic carcinoma (Lampson et al., 1983) , histological type in carcinoma of the lung (Doyle et al., 1985) , degree of tumour progression in melanoma (Brocker et al., 1985 , Lopez-Nevot et al., 1986 and also with the malignancy of B cell lymphomas (M6ller et al., 1987) . Contrary to the findings described by others (Morburg et al., 1986) , no correlation between the loss of HLA class I expression and the degree of cell differentiation was found in colorectal carcinoma (Gutierrez et al., 1987) . However, it was noted that in laryngeal carcinomas most of the tumours consisting of less differentiated cells were HLA class I negative (6/7) whereas among moderately or well differentiated carcinomas there was only one HLA class I negative tumour. These data suggest that the loss of HLA class I expression is closely related to the degree of cell differen- tiation in laryngeal carcinoma. This loss may also represent an escape mechanism from cytotoxic T-cell mediated lysis, as these cells recognise tumour antigens in association with HLA class I molecules (Fentestein, 1987) . On the other hand, the loss of HLA class I expression may lead to increased sensitivity of tumour cells to lysis by NK cells . In gastric carcinoma, however, the less differentiated cells are mainly HLA class I positive exhibiting higher levels of expression than those observed in normal gastric mucosa. This increased HLA class I expression may facilitate their metastatic progression by means of diminishing their susceptibility to NK lysis.
When HLA class I expression on primary tumours was compared with autologous metastases in laryngeal carcinoma, some HLA class I positive primary tumours demonstrated HLA class I negative metastases and vice versa. These data suggest that several mechanisms of clonal selection may coexist during the course of tumour progression, given the fact that there does not seem to be a simple pattern of change in HLA class I expression. The differences in HLA class I expression between primary tumours and autologous metastases in colorectal and gastric carcinoma, basically consisting of a decrease in the number of HLA class I positive cells, were observed only in a small number of cases.
Anti-HLA class I MoAb directed against a monomorphic determinant does not effectively detect selective losses of HLA-A, B or C antigen expression. However, when using isotypic MoAbs directed against HLA-B specific determinants it became possible to record losses of HLA-B antigens in all three types of tumour studied. The reactivity of the lymphoid infiltrate with these antibodies served as an internal control. In these three tumours it was also possible to confirm the absence of HLA-B molecules by means of polymorphic MoAbs directed against the serologically detected specificities found in autologous blood lymphocytes by standard cytotoxicity assays. In one case of HLA class I positive gastric carcinoma HLA-B reactivity was not observed and anti-HLA-A MoAb assays were found to be negative. As HLA-C antigens are generally expressed in much lower amounts than HLA-A or B, the antibody W6/32 may, in this case, recognise HLA class I-like molecules which are distinct from HLA-A, B or C.
These data speak in favour of the use of isotypic MoAbc but also polymorphic antibodies in order more accurately tc define alterations in HLA class I expression. Even with isotypic MoAbs it would be difficult to detect a partial loss of antigen expression if the defect was located in the polymorphic domains of the molecule. Selective losses of MHC class I antigens have been described in murine tumours (Garrido et al., 1976b) . These losses of K or D molecules were correlated with an enhanced metastatic ability (Eisenbach et al., 1983) . It has recently been reported that the resistance of certain Burkitt lymphomas to lysis by autologous cytotoxic T-lymphocytes may be due to the selective loss of HLA-A1 1 antigen expression (Masucci et al., 1988) . Selective losses of HLA-B locus products have been recently reported in colorectal carcinomas (Garrido, 1988; Smith et al., 1988) . The selective loss of HLA-B antigens may give rise to a similar state. It would also be worthwhile to study whether selective losses of HLA class I antigen expression affect certain specificities more frequently than others.
Southern blot analyses were performed to try to ascertain whether the changes in HLA class I expression could be due to a genomic structural alteration (rearrangement or gross deletion) or perhaps to changes in the methylation pattern of the CCGG base sequences (using the isoschizomeric pair of restriction enzymes MspI and HpaII which are differentially sensitive to methylation of the CCGG moiety). Data have been obtained on the murine GR9 tumour which substantiate different class I methylation patterns between class I positive and negative tumour clones (Bonal et al., 1986) . The loss of H-2 molecules in SV-40 and radiation leukaemia virus induced tumours is associated with H-2 class I gene rearrangement or CCGG hypermethylation (Rogers et al., 1983 , Meruelo et al., 1986 . Loss of HLA class I gene restriction fragments has been described in human melanoma (Angelini et al., 1986) and colorectal carcinoma (Bar-Eli et al., 1987) . When tumour DNA was compared with that from normal autologous cells it was not possible to detect clear genomic alterations with the enzymes and probe (HLA class I) used. In the present study HLA class I positive and negative tumours as well as tumours with selective losses of HLA-B locus products were investigated. The cause of altered HLA class I expression in our tumours may therefore be mediated by a transcriptional event. Selective losses of HLA molecules without DNA damage suggest that the Blocus can be regulated independently from the A-locus and as similarly described on murine K and D class I molecules (Gmur et al., 1980) .
Further studies remain to be carried out in order to analyse the alteration in histocompatibility antigens expression and its role in tumour progression and metastases.
